Cited by 42Chronic Disease Management StrategiesClinical practice guidelines implementationPatient-Provider Communication in Healthcare

Person-centered models for cardiovascular care: a review of the evidence: a scientific statement from the American Heart Association

Open access
Rossi, Laura P., Granger, Bradi B., Bruckel, Jeffrey T., Crabbe, Deborah L., Graven, Lucinda J., Newlin, Kimberly S., Streur, Megan M., Vadiveloo, Maya K. +5 more·2023·Circulation

Abstract

Cardiovascular disease remains the leading cause of death and disability in the United States and globally. Disease burden continues to escalate despite technological advances associated with improved life expectancy and quality of life. As a result, longer life is associated with multiple chronic cardiovascular conditions. Clinical guidelines provide recommendations without considering prevalent scenarios of multimorbidity and health system complexities that affect practical adoption. The diversity of personal preferences, cultures, and lifestyles that make up one’s social and environmental context is often overlooked in ongoing care planning for symptom management and health behavior support, hindering adoption and compromising patient outcomes, particularly in groups at high risk. The purpose of this scientific statement was to describe the characteristics and reported outcomes in existing person-centered care delivery models for selected cardiovascular conditions. We conducted a scoping review using Ovid MEDLINE, Embase.com, Web of Science, CINAHL Complete, Cochrane Central Register of Controlled Trials through Ovid, and ClinicalTrials.gov from 2010 to 2022. A range of study designs with a defined aim to systematically evaluate care delivery models for selected cardiovascular conditions were included. Models were selected on the basis of their stated use of evidence-based guidelines, clinical decision support tools, systematic evaluation processes, and inclusion of the patient’s perspective in defining the plan of care. Findings reflected variation in methodological approach, outcome measures, and care processes used across models. Evidence to support optimal care delivery models remains limited by inconsistencies in approach, variation in reimbursement, and inability of health systems to meet the needs of patients with chronic, complex cardiovascular conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001141

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many published qualitative systematic reviews and meta-analyses exist on self-directed digital health interventions.

    “There are, however, many published qualitative systematic reviews and meta-analyses on this topic.25–29”

    From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [26]

    The Limitations section describes this paper as a scoping review of cardiovascular care models, and its tables include some digital or home-based interventions. Searches for systematic reviews, meta-analyses, and digital self-management found no passage stating that many qualitative systematic reviews and meta-analyses exist on self-directed digital health interventions. (LLM, conf=0.70)

    Experimental — accuracy not yet measured
  • Weight management has myriad benefits in T2D, including reductions of A1C and hepatic steatosis, and improvement in cardiovascular risk factors.

    “Weight management has myriad benefits in T2D, including reductions of A1C and hepatic steatosis, and improvement in cardiovascular risk factors.26,29”

    From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [26]

    The Outcome Evaluation: Cost of Care table mentions HbA1c and cardiovascular risk measures in an evaluation of a nurse-led care model, not as benefits of weight management in T2D. Searches for weight management, hepatic steatosis, and weight-related glycemic improvement found no passage in our copy addressing the claimed benefits; the retrieved passages have no page numbers. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Some weight regain from the nadir at 12 to 18 months postsurgery is common.

    “Some weight regain from the nadir at 12 to 18 months postsurgery is common.26”

    From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [26]

    The Cardiac and Stroke Rehabilitation Care Models section discusses outcomes after cardiovascular events, not weight trajectories after bariatric surgery. Searches for “weight regain,” “bariatric surgery,” and the claimed 12-to-18-month interval found no passage in our copy addressing whether regain from the postsurgical nadir is common; the available passages have no page numbers. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • The beneficial effect on kidney and cardiovascular events with SGLT-2i was observed in patients regardless of background RASi or GLP-1 RA use, suggesting an independent and incremental benefit of SGLT-2i.

    “The beneficial effect on kidney and cardiovascular events with SGLT-2i was observed in patients regardless of background RASi26 or GLP-1 RA10 use, suggesting an independent and incremental benefit of SGLT-2i.”

    From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [26]

    The supplied passages and the searched sections on behavioral changes and adherence and care outcomes (page numbers unavailable) discuss care-delivery models and guideline-directed therapy, not SGLT-2 inhibitor effects. Searches for SGLT-2 inhibitors, RAS inhibitors, GLP-1 receptor agonists, and kidney outcomes found no passage addressing whether benefits persist regardless of background therapy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured
  • Epidemiologic data from observational cohorts suggest that higher levels of physical activity are associated with a lower risk of progression to HF among adults with elevated cardiac biomarkers.

    “Moreover, epidemiologic data from observational cohorts suggest that higher levels of physical activity are associated with a lower risk of progression to HF among adults with elevated cardiac biomarkers.26”

    From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [26]

    The Discussion mentions physical activity as one component of a care intervention, but does not report an association between activity levels and progression to heart failure. Searches for cardiac biomarkers and incident heart failure found no passage addressing the claimed observational-cohort finding. Page numbers were unavailable for these passages. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [22]22. Veritas Health Innovation. Covidence systematic review software. Accessed April 25, 2022. https://www.covidence.org/
  2. [78]78. Qian C, Zhong D, Shen Y, Du Q. Evaluation of clinical efficacy of transitional care mode for patients with strokes. Int J Clin Exp Med. 2019;12:981-988.

Cited by

Sorted by citations

Authors
Rossi, L. P., Granger, B. B., Bruckel, J. T., Crabbe, D. L., Graven, L. J., Newlin, K. S., Streur, M. M., Vadiveloo, M. K., Walton-Moss, B. J., Warden, B. A., Volgman, A. S., Lydston, M., & on behalf of the American Heart Association Complex Cardiovascular Patient and Family Care Committee of the Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research
Venue
Circulation
Published
2023-08-08
Volume
148
Issue
6
Pages
512-542
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W4383711226
Cited by
42
References
201
Citations by year
2026: 23 · 2025: 15 · 2024: 4
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
Keywords
person-centred care, multimorbidity, chronic cardiovascular disease, patient preferences, shared decision-making, clinical decision support, symptom management, health system complexity, care planning, patient outcomes
MeSH terms
American Heart Association, Cardiovascular Diseases, Delivery of Health Care, Humans, Palliative Care, Quality of Life, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review